{"name":"Cure Therapeutics","slug":"cure-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQcmN3cU5WS1lTeFVncWFKdS1QLVF0ZWdEUWNRTnUwWFRFOG5fbjFsaXBwZFNCcGs5VDNYbVVpczREZ19hSU1vb2thZGpIUVo4RW5fZlZHdVpjQVJLajYwdHlCNGxsdlhrWV91Zlo5XzIzYkxqbW9kd3lIN2h3NHAwVUU2ejYwVVhISEl1SkcxTW8tdWRzNmp2VGsybVdPT2VOakhHWUhNbFUxQ0h6VE5sRVlhSnFDa1M1NVAwZ2RMVTZfTk5vcWZ3X0J5d1BRYjRwU3JqMjZBa3FZWE5B?oc=5","date":"2026-03-31","type":"deal","source":"PR Newswire","summary":"Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders - PR Newswire","headline":"Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxQeFJUQ2p3TVZvcHBmYUV3eW1XMDQ4Tng1NS1PX1kwblh4X2FQV3NhSmxSMkZPeXdTS18wNHpfQnF4SGFhWGxuU2l3VTJWNXZVVUxZbG9Ob2JnX1liS0xURTNwTDJBSjBRZUJMMm1NNlVNUlcyWDVJMGhtNDBaSXBFQ0JUTWU2bTJIN3h3MTdWb2lWUkY5Y0hMMU5kYXFYMVRIbzZlZ0c1cWxKT09VaG9WYTNITVc4R3FGbktFcE1YYkhJSm5JaWgwWXZfRXFGSVJwSDEzVGVHSS1XcmdMMEN1SHRrY1RFODVaVTRtaDl3ZDRqTDRqSDNFbW9NTWlPREdyYWlKWUtQblFUYU4tSUYtbmRSR2lfVzEyX1o0eW9fanJKaXBPb1N3?oc=5","date":"2026-03-11","type":"pipeline","source":"GlobeNewswire","summary":"60 Degrees Pharmaceuticals Announces All Patients Cured of - GlobeNewswire","headline":"60 Degrees Pharmaceuticals Announces All Patients Cured of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQUnZxaHJvbnIyejFZcXpsaFJzZmZRTHEzQUdiZ3pET2tHdTNORFppTWp3RXJhR2Jtc2FZYU02YTBZSlQyR2RVOUZ0Rlh2U1pidUdqc3Jtd0dGT1hsVklObUU5VEtLRmcwLUJfZHZkQ3hKLVFFUU5ITnlWTVc2WFpmeDVDT2UxVS0xYTdSTG5yZERsQVE2MURNWU1uUUlBRUQ0dGdKN2REM3hxNzUyd1c4Q21XRQ?oc=5","date":"2026-03-11","type":"trial","source":"Stock Titan","summary":"In tiny trial, malaria drug combo cleared a stubborn tick-borne infection - Stock Titan","headline":"In tiny trial, malaria drug combo cleared a stubborn tick-borne infection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPdEc0OUhJcFlVcGtvQllhQXkxd29xRnllZVRMRnVPaEdqbFoyOVIwOXk3eEs4UkpQSmhLM0ZzaXJWdjAzdmdFSHdzNnJVcjFVck53bUhqQnhoQS1lcm4zM3FFTzF1YUdDSTFLVjNuaDhLRlFlakRYc19JX3hFeDJDbGUybjNXdXdtMU5vUTZhZ204MXNnX0M5Um1IcnRDZlBnZzg0S2Q2cktVYVlnOGc?oc=5","date":"2026-03-05","type":"pipeline","source":"Pharmaceutical Technology","summary":"Targeted therapies to join chemo as oncology treatment backbone - Pharmaceutical Technology","headline":"Targeted therapies to join chemo as oncology treatment backbone","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-20","type":"regulatory","source":"PR Newswire","summary":"Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovatio","headline":"Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Sch","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxQSlBBU1JBc2VUSWRpclFmN1cwU0pFSVBJdjl0VUlrcWhvZmNTMVU2X0dfZElQSG5aZTNTek9SZDVnbmtvZ2ZFbHF2dGlUWm9vbU5OeVNGc3hMN2hyNEZqMFVCNW9aWjlNbEhZeWhrZ05KR3NpNnhLX2NJdDRRU2tOeWFhY0lBcWo5bGRndnhyX2FmSjdjQzZWMkRVU1BRWm5QYnFYeDJoaGNQUTdnemk0bzE1cE5pSHRzQ1NfZndYQ0otZF96Y0NsVTdQbS1JTlhmclN6X0FMN3Z1ZVJlZ3Z1Q210Y3hxTVUwMFFIbGFqZFlfc25WTnRRQ2VYSVBOWFdreGNGOUZDaWl3VTBnemdyWl81anlNbF9lemtfVlNieEJmTzRiODFFM2dEaHdKYVE3RWRN?oc=5","date":"2026-01-27","type":"trial","source":"Business Wire","summary":"Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia - Business Wire","headline":"Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for th","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOTEVJZVB3UjlXYmxtdXhZWFpTOXJHWXpGRHNObkdjUl9nRUxVVUxTU21ZWHNLU0dvTGtNVjdLbkc0ZHZ2WUYtNjQ4c29iNjI5Q1V1LUY5cTY0dEI2SzdJOUtKM2tLd25iZS0ycC1JSnBDdE1pN3lJRnhuS1hEOWhnMzI5TFU4VU15UzNXNDFTdnBLUnIwMGpOYUxscW4zSFRTbmNkeF9BSVNuLU1VUTV3ODVvem5mOW8xQ3hfRkluNzdfdw?oc=5","date":"2025-12-23","type":"trial","source":"seekingalpha.com","summary":"Atea Pharmaceuticals: Potential Best-In-Class HCV Cure With Pivotal Readouts In 2026 - seekingalpha.com","headline":"Atea Pharmaceuticals: Potential Best-In-Class HCV Cure With Pivotal Readouts In 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1iTEw4UmJiSHg0bFJFSmg4SkRtZ3VxczVsUTQxWHJsMmt5aUplUTNyaDVuLTdmbENFN0JxWnlCQkdPUG42UTdqcjBVRVo1SUEydElvRFN6Wjd4a2s1d1lzUjdzSGNIemlsU0FtX2d4Z0RUeGxB?oc=5","date":"2025-12-18","type":"pipeline","source":"CureVac","summary":"CureVac is now part of the BioNTech Group - CureVac","headline":"CureVac is now part of the BioNTech Group","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNb0JtcWQ3LWhIM0F5NFZWWjZFWDkzYlNxaFNGNGdmUTFxRkYtaXFVNWZUbl90aDdlMHdwd3pfcGZHbWVVOV9tcmdsNm9GVl8yOW9hWU5wSy14cjNURzVCUEZjLUN1U0VsVlc2Z09JV2hkeDhDNWVuc0toM3JnaE55c0xzbmJZZ2dUczNlRVowMUdDMUV0ZWVKa1B5QWhrbXlUMGh3YnZtZzQ?oc=5","date":"2025-12-17","type":"deal","source":"PharmaTimes","summary":"Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline - PharmaTimes","headline":"Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNZnNnMXp6amZUWk1GMjE1M3JlcTdqNjJjSmhqdzdHbkpHM3gybTBxVThIczQxMXk1TGVXR2hXck9DakdUZ1h1Q1IwUXhpaVlFbjd0TklSa1pZbnV6S3UzVzdOOUt5SUNIak9XRUtFYjgwa2dIZE1BQTBmdUxhV05ZTTNGQTNIYkdWVkE?oc=5","date":"2025-12-14","type":"trial","source":"Yahoo Finance","summary":"Terns Pharmaceuticals (TERN) Climbs 53% on Stellar Leukemia Treatment Trial - Yahoo Finance","headline":"Terns Pharmaceuticals (TERN) Climbs 53% on Stellar Leukemia Treatment Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQVE9jUzBkYUw5aHJHNWxyT2toM09rTExxZHpDZkx1bVdPMWktMENHWkJIdGRGZTBJNTdVN1dmdDNDYTBXSXJodk1pbmJ3LUgxTnd4bVc0WVNyTGxLQzhZRGdCN3pTVWFGTVZOZUZnQXRGaEpxWTE3QnlEUGN1ZE9PZFdyUFNNNnRKSUVBN2dCQWpwRUhXSzRsVC12dGZvUGs3T3psWU5icl9FNkg0NTZuag?oc=5","date":"2025-10-16","type":"deal","source":"Pharmaceutical Executive","summary":"Pharma Collaborations Focused on Advancing Antibody-Drug Conjugates and Delivering Treatments for Autoimmune Diseases - Pharmaceutical Executive","headline":"Pharma Collaborations Focused on Advancing Antibody-Drug Conjugates and Delivering Treatments for Autoimmune Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxQNVg1cVhlVHdYQVlBaGE0cDVBVkd4U3hVQmRDMjlXQ0daN25ZRVJUbERCVGZHZVZEaVlrSE85UWk0dER2NTBjX3FackFFN29RSko3b2VuZmNVVEcwS1NSTGZTeDMxczRVSTR3djI1MWJDM1VoNVhBNGtaMG8zMTRYbjZtM3p6WkNlZ19JSkhnaVpZODVpVnVSczB1aGpvM0RfWW1yZVU1ck10ZkNlVnI3SkhvbGJaeHYtZFFTUjBiTm1RdHlZV3A0VzdFelFaTHFLa2VCWmJicjR4MTZlclVHcHhabkxHblU?oc=5","date":"2025-08-27","type":"deal","source":"News-Medical","summary":"CURE GABA-A and Grann Pharmaceuticals announce global partnership to advance rare neurological therapies - News-Medical","headline":"CURE GABA-A and Grann Pharmaceuticals announce global partnership to advance rare neurological therapies - News","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}